32 related articles for article (PubMed ID: 36502788)
1. Vinpocetine improves dyskinesia in Parkinson's disease rats by reducing oxidative stress and activating the Wnt/β-catenin signaling pathway.
Ji M; Niu SQ; Mi HY; Jiang P; Li Y
Chem Biol Drug Des; 2024 Jan; 103(1):e14358. PubMed ID: 37749299
[TBL] [Abstract][Full Text] [Related]
2. SYNJ1 rescues motor functions in hereditary and sporadic Parkinson's disease mice by upregulating TSP-1 expression.
Tian Y; Yi S; Guo W; Feng C; Zhang X; Dong H; Wang K; Li R; Tian Y; Gan M; Wu T; Xie H; Gao X
Behav Brain Res; 2023 Aug; 452():114569. PubMed ID: 37419331
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Improvement Effect of Nervonic Acid Extracted from Xanthoceras Sorbifolium Bunge Oil on Antioxidant Response and Inflammatory Response in Parkinson's Disease.
Hu D; Cui Y; Zhang J
J Integr Neurosci; 2023 Nov; 22(6):161. PubMed ID: 38176921
[TBL] [Abstract][Full Text] [Related]
4. Discovery of conformationally constrained c-Abl inhibitors with potential neuroprotective effects against Parkinson's disease.
Yang Z; Ai Y; Wu G; Guo F; Yang Z; Cheng B; Zhang L; Li M; Chen J; Zhang J; Zhang T
Bioorg Med Chem; 2023 Dec; 96():117532. PubMed ID: 38006642
[TBL] [Abstract][Full Text] [Related]
5. Correction to: Paeoniforin ameliorates cognitive impairment in Parkinson's disease via JNK/p53 signaling.
He ZQ; Huan PF; Wang L; He JC
Metab Brain Dis; 2024 Jan; 39(1):255-261. PubMed ID: 37804410
[No Abstract] [Full Text] [Related]
6. Progesterone exerts a neuroprotective action in a Parkinson's disease human cell model through membrane progesterone receptor α (mPRα/PAQR7).
Castelnovo LF; Thomas P
Front Endocrinol (Lausanne); 2023; 14():1125962. PubMed ID: 36967764
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics.
Deb S; Dutta A; Phukan BC; Manivasagam T; Justin Thenmozhi A; Bhattacharya P; Paul R; Borah A
Neurochem Int; 2019 Oct; 129():104478. PubMed ID: 31145971
[TBL] [Abstract][Full Text] [Related]
8. Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease.
Marchetti B
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477246
[TBL] [Abstract][Full Text] [Related]
9. L-Theanine alleviates MPTP-induced Parkinson's disease by targeting Wnt/β-catenin signaling mediated by the MAPK signaling pathway.
Ratih K; Lee YR; Chung KH; Song DH; Lee KJ; Kim DH; An JH
Int J Biol Macromol; 2023 Jan; 226():90-101. PubMed ID: 36502788
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
[TBL] [Abstract][Full Text] [Related]
11. Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair.
L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Deleidi M; Serapide MF; Pluchino S; Marchetti B
J Neurosci; 2012 Feb; 32(6):2062-85. PubMed ID: 22323720
[TBL] [Abstract][Full Text] [Related]
12. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
[TBL] [Abstract][Full Text] [Related]
13. Mangiferin alleviates 6-OHDA-induced Parkinson's disease by inhibiting AKR1C3 to activate Wnt signaling pathway.
Huang W; Wang Y; Huang W
Neurosci Lett; 2024 Jan; 821():137608. PubMed ID: 38142926
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease.
Zhou T; Zu G; Zhang X; Wang X; Li S; Gong X; Liang Z; Zhao J
Neuropharmacology; 2016 Feb; 101():480-9. PubMed ID: 26525190
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
